Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine and Oxaliplatin in Metastatic Pancreatic Carcinoma
NCT00004190Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Oct 1999
- Primary completion
- Apr 2003
- Modality
- DNA Intercalators/Alkylators
- Countries
- 2
01
Overview
A Phase 2 trial of oxaliplatin in pancreatic cancer (PC), sponsored by Cancer and Leukemia Group B. Started Oct 1999; status: completed.
02
Drugs
oxaliplatin
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00004190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004190.